These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 7989935)

  • 1. Immunologic, cytogenetic, and clinical characterization of childhood acute lymphoblastic leukemia with the t(1;19) (q23; p13) or its derivative.
    Pui CH; Raimondi SC; Hancock ML; Rivera GK; Ribeiro RC; Mahmoud HH; Sandlund JT; Crist WM; Behm FG
    J Clin Oncol; 1994 Dec; 12(12):2601-6. PubMed ID: 7989935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19).
    Raimondi SC; Behm FG; Roberson PK; Williams DL; Pui CH; Crist WM; Look AT; Rivera GK
    J Clin Oncol; 1990 Aug; 8(8):1380-8. PubMed ID: 2380759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Childhood pre-B cell acute lymphoblastic leukemia with translocation t(1;19)(q21.1;p13.3) and two additional chromosomal aberrations involving chromosomes 1, 6, and 13: a case report.
    Wafa A; As'sad M; Liehr T; Aljapawe A; Al Achkar W
    J Med Case Rep; 2017 Apr; 11(1):94. PubMed ID: 28385156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood acute lymphoblastic leukemia with the MLL-ENL fusion and t(11;19)(q23;p13.3) translocation.
    Rubnitz JE; Camitta BM; Mahmoud H; Raimondi SC; Carroll AJ; Borowitz MJ; Shuster JJ; Link MP; Pullen DJ; Downing JR; Behm FG; Pui CH
    J Clin Oncol; 1999 Jan; 17(1):191-6. PubMed ID: 10458233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
    Uckun FM; Sensel MG; Sather HN; Gaynon PS; Arthur DC; Lange BJ; Steinherz PG; Kraft P; Hutchinson R; Nachman JB; Reaman GH; Heerema NA
    J Clin Oncol; 1998 Feb; 16(2):527-35. PubMed ID: 9469337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatric B-cell precursor acute lymphoblastic leukaemia with t(1;19)(q23;p13): clinical and cytogenetic characteristics of 47 cases from the Nordic countries treated according to NOPHO protocols.
    Andersen MK; Autio K; Barbany G; Borgström G; Cavelier L; Golovleva I; Heim S; Heinonen K; Hovland R; Johannsson JH; Johansson B; Kjeldsen E; Nordgren A; Palmqvist L; Forestier E
    Br J Haematol; 2011 Oct; 155(2):235-43. PubMed ID: 21902680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability of the t(1;19)(q23;p13) from surface antigen phenotype: implications for screening cases of childhood acute lymphoblastic leukemia for molecular analysis: a Pediatric Oncology Group study.
    Borowitz MJ; Hunger SP; Carroll AJ; Shuster JJ; Pullen DJ; Steuber CP; Cleary ML
    Blood; 1993 Aug; 82(4):1086-91. PubMed ID: 8353275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of identical E2A/PBX1 fusion transcripts occurs in both pre-B and early pre-B immunological subtypes of childhood acute lymphoblastic leukemia.
    Izraeli S; Henn T; Strobl H; Ludwig WD; Kovar H; Haas OA; Harbott J; Bartram CR; Gadner H; Lion T
    Leukemia; 1993 Dec; 7(12):2054-6. PubMed ID: 8255105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of t(1;19)/ TCF3-PBX1 in childhood acute lymphoblastic leukemia in the context of Berlin-Frankfurt-Münster-based protocols.
    Felice MS; Gallego MS; Alonso CN; Alfaro EM; Guitter MR; Bernasconi AR; Rubio PL; Zubizarreta PA; Rossi JG
    Leuk Lymphoma; 2011 Jul; 52(7):1215-21. PubMed ID: 21534874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia.
    Secker-Walker LM; Berger R; Fenaux P; Lai JL; Nelken B; Garson M; Michael PM; Hagemeijer A; Harrison CJ; Kaneko Y
    Leukemia; 1992 May; 6(5):363-9. PubMed ID: 1593901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a new human pre-B acute lymphoblastic leukemia cell line (KMO-90) with 1;19 translocation carrying p53 gene alterations.
    Sotomatsu M; Hayashi Y; Kawamura M; Yugami S; Shitara T
    Leukemia; 1993 Oct; 7(10):1615-20. PubMed ID: 8412323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. t(12;17)(p13;q21) in early pre-B acute lymphoid leukemia.
    Krance RA; Raimondi SC; Dubowy R; Estrada J; Borowitz M; Behm F; Land VJ; Pullen J; Carroll AJ
    Leukemia; 1992 Apr; 6(4):251-5. PubMed ID: 1534130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification.
    De Zen L; Orfao A; Cazzaniga G; Masiero L; Cocito MG; Spinelli M; Rivolta A; Biondi A; Zanesco L; Basso G
    Leukemia; 2000 Jul; 14(7):1225-31. PubMed ID: 10914546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
    Hann IM; Richards SM; Eden OB; Hill FG
    Leukemia; 1998 Aug; 12(8):1249-55. PubMed ID: 9697880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study.
    Trueworthy R; Shuster J; Look T; Crist W; Borowitz M; Carroll A; Frankel L; Harris M; Wagner H; Haggard M
    J Clin Oncol; 1992 Apr; 10(4):606-13. PubMed ID: 1548523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
    Ludwig WD; Teichmann JV; Sperling C; Komischke B; Ritter J; Reiter A; Odenwald E; Sauter S; Riehm H
    Klin Padiatr; 1990; 202(4):243-52. PubMed ID: 2203938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22).
    Griffin TC; Tomlinson GE; Raimondi SC; Sandoval C; Timmons CF; Rosenfield C; Carroll AJ; Schneider NR
    Leukemia; 1992 Jun; 6(6):535-40. PubMed ID: 1602792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients.
    Kansal R; Deeb G; Barcos M; Wetzler M; Brecher ML; Block AW; Stewart CC
    Am J Clin Pathol; 2004 Apr; 121(4):512-25. PubMed ID: 15080303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.
    Abshire TC; Buchanan GR; Jackson JF; Shuster JJ; Brock B; Head D; Behm F; Crist WM; Link M; Borowitz M
    Leukemia; 1992 May; 6(5):357-62. PubMed ID: 1534389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): a collaborative study of 40 cases.
    Pui CH; Frankel LS; Carroll AJ; Raimondi SC; Shuster JJ; Head DR; Crist WM; Land VJ; Pullen DJ; Steuber CP
    Blood; 1991 Feb; 77(3):440-7. PubMed ID: 1991161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.